-
Something wrong with this record ?
Anti-interleukin-6 therapies for hospitalized patients with COVID-19 : a protocol for a prospective meta-analysis of randomized trials : 19 February 2021
- Published
-
[Geneva] : World Health Organization, [2021]
©2021
- Pagination
- 12 stran
Language English Country Switzerland
Persistent link
https://www.medvik.cz/link/MED00206374
- MeSH
- Betacoronavirus MeSH
- COVID-19 MeSH
- Disease Outbreaks MeSH
- Interleukin-6 MeSH
- Meta-Analysis as Topic MeSH
- Randomized Controlled Trials as Topic MeSH
- Conspectus
- Veřejné zdraví a hygiena
- NML Fields
- veřejné zdravotnictví
- NML Publication type
- publikace WHO
The overall objective of this prospective meta-analyses (PMA) is to estimate the effect of anti-IL-6 therapy compared with usual care in hospitalized patients with suspected or confirmed COVID-19. The primary comparison is of the class effect of anti-IL-6 therapies. It will also estimate the effects of specific anti-IL-6 therapies.
Bibliography, etc.
Obsahuje bibliografické odkazy
| Owner | Details | Services |
|---|---|---|
| NLK | NLK Shelf no. online [0] | see E-resources |
- 000
- 00000nam a2200000 i 4500
- 001
- MED00206374
- 003
- CZ-PrNML
- 005
- 20210226191810.0
- 008
- 210226s2021 sz eo 000 0|eng||
- 009
- W
- 040 __
- $a ABA008 $b cze $d ABA008 $e rda
- 041 0_
- $a eng
- 044 __
- $a sz
- 072 _7
- $a 614 $x Veřejné zdraví a hygiena $2 Konspekt $9 14 $7 sk136314
- 110 2_
- $a Světová zdravotnická organizace $7 kn20010711442
- 245 10
- $a Anti-interleukin-6 therapies for hospitalized patients with COVID-19 : $b a protocol for a prospective meta-analysis of randomized trials : 19 February 2021
- 264 _1
- $a [Geneva] : $b World Health Organization, $c [2021]
- 264 _4
- $c ©2021
- 300 __
- $a 12 stran
- 336 __
- $a text $b txt $2 rdacontent
- 337 __
- $a počítač $b c $2 rdamedia
- 338 __
- $a online zdroj $b cr $2 rdacarrier
- 347 __
- $a textový soubor $b PDF $2 rda
- 504 __
- $a Obsahuje bibliografické odkazy
- 520 3_
- $a The overall objective of this prospective meta-analyses (PMA) is to estimate the effect of anti-IL-6 therapy compared with usual care in hospitalized patients with suspected or confirmed COVID-19. The primary comparison is of the class effect of anti-IL-6 therapies. It will also estimate the effects of specific anti-IL-6 therapies.
- 650 07
- $a veřejné zdravotnictví $7 nlk20040148357 $2 mednas
- 650 07
- $a COVID-19 $7 D000086382 $2 czmesh
- 650 07
- $a Betacoronavirus $7 D000073640 $2 czmesh
- 650 07
- $a epidemický výskyt choroby $7 D004196 $2 czmesh
- 650 07
- $a interleukin-6 $7 D015850 $2 czmesh
- 650 07
- $a metaanalýza jako téma $7 D015201 $2 czmesh
- 650 07
- $a randomizované kontrolované studie jako téma $7 D016032 $2 czmesh
- 655 _4
- $a publikace WHO $7 nlk20040156070
- 856 41
- $u https://www.who.int/publications/i/item/WHO-2019-nCoV-PMA_protocols-anti-IL-6-2021.1 $y plný text volně přístupný
- 910 __
- $a ABA008 $b online $y 0
- 990 __
- $a 20210226191810 $b ABA008
- 991 __
- $a 20210226191810 $b ABA008
- 999 __
- $a ok $b medvik21 $g 1625575 $s 222289
- BAS __
- $a 30 $a 49
- LZP __
- $b 2021online
